Brieflands
Journal finderSearch
·
Sign in

Iranian Journal of Pharmaceutical Research

e-ISSN 1726-6890
p-ISSN 1735-0328
Home
Archives
    Current IssueAll IssuesIn PressAccepted Manuscripts
Search
Instructions
About Journal
    Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit manuscript
  1. Brieflands
  2. /
  3. journals
  4. /
  5. Iranian Journal of Pharmaceutical Research
  6. /
  7. Articles
  8. /
  9. Insulin and TLR4 Inhibitor Improve Motor Impairments in a Rat Model of Parkinson’s Disease
  10. /
  11. Scopus by Title (Ref)
Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

5 results·Updated October 03, 2026
← Back to article
1

Exosome-liposome hybrid system with antioxidant and anti-inflammatory activities targeting glial cells for the treatment of central nervous system diseases

Chinese Chemical Letters

September 2026

Chen Y.

2

Taking its TOLL: the role of toll-like receptor 4 in human health and disease, and its potential as a therapeutic target

Frontiers in Immunology

2026

Crammond P.

Open Access

3

Neurodegenerative Disease Molecular Therapeutics based on Structural Activity Connections of Microglia Activation and Priming: A Comprehensive Review

Current Topics in Medicinal Chemistry

2026

Abubakar M.

4

Gastrointestinal In Situ Self-Assembled Gastrodia Elata Polysaccharide Hydrogel Enables Parkinson's Disease Therapy via Gut-Brain Axis Modulation

Small

2026

Lei T.

5

Potentials of cepharanthine and tomatidine as novel LpxC and TLR4 inhibitors to mitigate gut-mediated inflammation in Parkinson’s disease: a high-throughput investigation through molecular docking and dynamic simulation

3 Biotech

July 2025

Roy R.

All Open Access, Green

Need help?

Editorial, submission and technical questions all go to the same desk.

Submit a ticket
Brieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.